Transfection with a cDNA encoding a Ser31 or Ser35 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance

This publication has 9 references indexed in Scilit:

• Comparison of the Expression of a Mutant Dihydrofolate Reductase under Control of Different Internal Promoters in Retroviral Vectors
  Human Gene Therapy, 1992
• Construction of a dominant selectable marker using a novel dihydrofolate reductase
  Gene, 1992
• Differential utilization of poly (A) signals between DHFR alleles in CHL cells
  Nucleic Acids Research, 1992
• Transfection of DHFR−and DHFR+mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase
  FEBS Letters, 1990
• Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells
  Blood, 1990
• Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells
  Nucleic Acids Research, 1990
• Crystal structure of human dihydrofolate reductase complexed with folate
  European Journal of Biochemistry, 1988
• Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.
  The Journal of Experimental Medicine, 1987
• Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro
  Biochemical Pharmacology, 1984